Paul Hossenlopp

3.8k citations

29 papers · 3.4k indexed · 1 hit paper · h-index 23

Endocrinology, Diabetes and Metabolism top 0.5%
- Growth Hormone and Insulin-like Growth Factors 19
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 9
- CRISPR and Genetic Engineering 3
- Viral Infectious Diseases and Gene Expression in Insects 2
Genetics top 5%
- Virus-based gene therapy research 3
- Genetic Syndromes and Imprinting 2
Cardiology and Cardiovascular Medicine top 5%
Surgery
- Pancreatic function and diabetes 4

Co-authors: M Binoux Danielle Seurin S Hardouin C Lassarre Monireh Roghani B Segovia Pierre Chambon Joël Couprie
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Molecular Biology
Partner nations: France United States Mali

In The Last Decade

Paul Hossenlopp

29 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies

Peers

Countries citing papers authored by Paul Hossenlopp

Since Specialization

Citations

This map shows the geographic impact of Paul Hossenlopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hossenlopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hossenlopp more than expected).

Fields of papers citing papers by Paul Hossenlopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hossenlopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hossenlopp. The network helps show where Paul Hossenlopp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Hossenlopp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Hossenlopp Line = papers co-authored together Paul Hossenlopp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Ig-like Structure of the C-Terminal Domain of Lamin A/C, Mutated in Muscular Dystrophies, Cardiomyopathy, and Partial Lipodystrophy Isabelle Krimm,Cecilia Östlund,Bernard Gilquin,Joël Couprie,Paul Hossenlopp,Jean‐Paul Mornon,Gisèle Bonne,Jean‐Claude Courvalin,Howard J. Worman,Sophie Zinn‐Justin	2002	231
2	The Uteroglobin Fold Isabelle Callebaut,Anne Poupon,R. Bally,Jean‐Philippe Demaret,Dominique Housset,J. Delettré,Paul Hossenlopp,Jean‐Paul Mornon	2000	33
3	Limited Proteolysis of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) : A Physiological Mechanism in the Regulation of IGF Bioavailability M Binoux,Claude Lalou,C Lassarre,C. Blat,Paul Hossenlopp	1994	24
4	Molecular forms of human IGF binding proteins: physiological implications. M Binoux,Monireh Roghani,Paul Hossenlopp,S Hardouin,M Gourmelen	1991	36
5	Cerebrospinal IGF Binding Proteins : Isolation and Characterization M Binoux,Monireh Roghani,Paul Hossenlopp,Odile Whitechurch	1991	12
6	Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J. Zapf,Christoph Schmid,H P Guler,M. Waldvogel,C Hauri,E. Futo,Paul Hossenlopp,M Binoux,E. R. Froesch	1990	132
7	Evidence of Enzymatic Degradation of Insulin-Like Growth Factor-Binding Proteins in the 150K Complex during Pregnancy* Paul Hossenlopp,B Segovia,C Lassarre,Monireh Roghani,MARIE BREDON,M Binoux	1990	301
8	Production of Insulin-Like Growth Factors and Their Binding Proteins by Rabbit Articular Chondrocytes: Relationships with Cell Multiplication* Béatrice Froger‐Gaillard,Paul Hossenlopp,M Adolphe,M Binoux	1989	80
9	Molecular Forms of Serum Insulin-Like Growth Factor (IGF)-Binding Proteins in Man: Relationships with Growth Hormone and IGFs and Physiological Significance* S Hardouin,M Gourmelen,P. Noguiez,Danielle Seurin,Monireh Roghani,Yves Le Bouc,Guilhèrme Pòvoa,Thomas J. Merimee,Paul Hossenlopp,M Binoux	1989	170
10	Purified Preparations of the Amniotic Fluid-Derived Insulin-Like Growth Factor-Binding Protein Contain Multimeric Forms that Are Biologically Active* Walker H. Busby,Paul Hossenlopp,M Binoux,David R. Clemmons	1989	48
11	Isolation from human cerebrospinal fluid of a new insulin‐like growth factor‐binding protein with a selective affinity for IGF‐II Monireh Roghani,Paul Hossenlopp,Pierre Lepage,Alain Balland,M Binoux	1989	98
12	Insulin-Like Growth Factor (IGF) and IGF-Binding Proteins: Comparison of Human Serum and Lymph* M Binoux,Paul Hossenlopp	1988	191
13	Heterogeneity of insulin‐like growth factor binding proteins between structure and affinity Paul Hossenlopp,Danielle Seurin,B Segovia,Ghyslaine Portolan,M Binoux	1987	70
14	Heterogeneity of insulin‐like growth factor binding proteins and relationships between structure and affinity S Hardouin,Paul Hossenlopp,B Segovia,Danielle Seurin,Ghyslaine Portolan,C Lassarre,M Binoux	1987	154
15	Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studiesbreakdown → Paul Hossenlopp,Danielle Seurin,Berta Segovia-Quinson,S Hardouin,M Binoux	1986	1093
16	EVIDENCE FOR PRODUCTION BY THE LIVER OF TWO IGF BINDING PROTEINS WITH SIMILAR MOLECULAR WEIGHTS BUT DIFFERENT AFFINITIES FOR IGF I AND IGF II. THEIR RELATIONS WITH SERUM AND CEREBROSPINAL FLUID IGF BINDING PROTEINS. M Binoux,S Hardouin,C Lassarre,Paul Hossenlopp	1982	62
17	Production of insulin‐like growth factors and their carrier by rat pituitary gland and brain explants in culture M Binoux,Paul Hossenlopp,C Lassarre,Nathalie Hardouin	1981	112
18	Somatomedin production by rat liver in organ culture. I. Validity of the technique. Influence of the released material on cartilage sulphation. Effects of growth hormone and insulin. M Binoux,Paul Hossenlopp,C Lassarre,Danielle Seurin	1980	12
19	A rapid procedure for purification of EcoRI endonuclease János Sümegi,Danielle Breedveld,Paul Hossenlopp,Pierre Chambon	1977	49
20	Animal DNA‐Dependent RNA Polymerases Paul Hossenlopp,Pierre Chambon,David J. Wells	1975	63

About Paul Hossenlopp

Paul Hossenlopp is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology, having authored 29 papers that have together received 3.4k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (19 papers), Metabolism, Diabetes, and Cancer (9 papers), Cancer, Hypoxia, and Metabolism (5 papers), Pancreatic function and diabetes (4 papers), Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers), Genetic Syndromes and Imprinting (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Cancer Research (555 citations) and Molecular Biology (1.7k citations). Paul Hossenlopp has collaborated with scholars based in France, United States and Mali. Frequent co-authors include M Binoux, Danielle Seurin, S Hardouin, C Lassarre, Monireh Roghani, B Segovia, Pierre Chambon, Joël Couprie, Sophie Zinn‐Justin and Jean‐Claude Courvalin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact